Skip to content
Arvee Laboratories logo

Arvee Laboratories

ARVEE NSE
₹187.50 8.92 (4.99%)
Market Cap
₹207 Cr
P/E
51.09

Arvee Laboratories (ARVEE) share price was ₹187.50 at the 28 Oct 2026 close; market capitalisation ₹207 Cr; P/E (TTM) 51.09; sector Chemicals. The share price rose 14.3% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 130.4% year on year to ₹17.23 Cr and net profit was ₹1.69 Cr, against ₹0.17 Cr a year earlier (compared with Jun 2025). Promoters held 73.50% of Arvee Laboratories in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 46/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹187.50 +23.50 +14.33% 1Y

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals
Market Cap
₹207 Cr
P/E (TTM)
51.09
EBITDA
₹3.90 Cr
Return on Equity
7.48%
Debt to Equity
0.03
Book Value
₹30.66
EPS (TTM)
₹3.67
52W High
₹290.78
52W Low
₹129.11

Price-based figures as of 28 Oct 2026, 14:13 IST · EPS basis: Standalone · TTM

Peer Comparison

Commodities › Chemicals › Specialty Chemicals

Pidilite Industries
₹1,389.6053.411,41,445 Cr13.071.48%22.36%28.48%15,689 Cr2,677 Cr
Gujarat Fluorochemicals
₹4,267.1077.4746,874 Cr6.000.07%7.25%10.13%5,334 Cr600 Cr
Navin Fluorine International
₹8,501.0055.1843,604 Cr10.980.18%16.70%18.66%3,734 Cr789 Cr
Aether Industries
₹1,588.4089.5921,082 Cr8.580.00%8.94%12.15%1,257 Cr235 Cr
Deepak Nitrite
₹1,488.4025.9220,301 Cr3.480.52%9.38%10.85%8,624 Cr784 Cr
Aarti Industries
₹437.3029.8715,856 Cr2.660.23%7.04%8.53%9,040 Cr531 Cr
Atul
₹5,225.5019.9315,385 Cr2.340.55%10.95%13.54%7,185 Cr788 Cr
Arvee Laboratories (this company)
₹187.5051.09207 Cr6.120.00%7.48%7.42%42 Cr4 Cr
Median 8 companies₹1,538.4052.2520,692 Cr6.060.21%9.16%11.50%6,260 Cr692 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

As of 2026-10-28
v2.0.0
46 Average
Overall score
Data confidence 100/100
surveillance:ASM1

Category scores

Quality Average 52
Returns, margins, earnings quality 22%
Valuation Poor 22
Cheap vs sector & own history 24%
Growth Good 58
Sales & profit trajectory 9%
Financial Health Strong 90
Solvency, leverage, coverage 9%
Momentum Strong 79
Trend strength, vol-adjusted 12%
Ownership Average 50
FII/DII/promoter flows 24%

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company is almost debt free.
  • Company is expected to give good quarter

Weaknesses

6
  • Stock is trading at 7.38 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -7.83% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of 5.88% over last 3 years.
  • Debtor days have increased from 91.4 to 121 days.

Technical Indicators

Oscillators

BearishNeutralBullish

Bearish

Bearish
2
Neutral
6
Bullish
1

Overall

BearishNeutralBullish

Bearish

Bearish
8
Neutral
6
Bullish
5

Moving Averages

BearishNeutralBullish

Bearish

Bearish
6
Neutral
0
Bullish
4

Growth Rate

Revenue Growth
-17.65% higher than 3Y

change over 1 year

Net Income Growth
19.05% higher than 3Y

change over 1 year

Cash Flow Change
42.86%

change over 1 year

EBITDA Margin Change
10.55%

change over 1 year Operating margin 14.45% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
7.6
8.91
7.7
6.14
10.6
12.53
8.91
6.45
7.48
3.45
9.78
10.8
17.23
Expenses
6.62
8.22
7.17
5.35
9.06
11.03
8.57
6.23
7.14
3.33
8.15
9.7
14.74
Operating Profit
0.98
0.69
0.53
0.79
1.54
1.5
0.34
0.22
0.34
0.12
1.63
1.1
2.49
OPM %
12.89%
7.74%
6.88%
12.87%
14.53%
11.97%
3.82%
3.41%
4.55%
3.48%
16.67%
10.19%
14.45%
Other Income
0.09
0.09
0.19
0.21
0.11
0.16
0.19
0.21
0.17
0.23
0.14
0.15
0.18
Interest
0.07
0.08
0.05
0.05
0.08
0.05
0.05
0.07
0.04
0.04
0.07
0.08
0.06
Depreciation
0.35
0.42
0.35
0.37
0.31
0.3
0.28
0.27
0.29
0.3
0.3
0.31
0.32
PBT
0.65
0.28
0.32
0.58
1.26
1.31
0.2
0.09
0.18
0.01
1.4
0.86
2.29
Tax %
24.62%
25%
25%
81.03%
25.4%
25.19%
25%
22.22%
5.56%
0%
-30.71%
38.37%
26.2%
Net Profit
0.49
0.21
0.24
0.12
0.94
0.98
0.15
0.07
0.17
0.01
1.83
0.52
1.69
EPS (₹)
0.44
0.19
0.22
0.11
0.85
0.89
0.14
0.06
0.15
0.01
1.66
0.47
1.53
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
26.82
34.44
47.78
54.9
45.42
47.38
40.33
61.35
30.35
38.49
31.51
41.26
Expenses
21.83
28.54
40.61
48.73
39.4
41.31
34.65
54.06
27.41
34.88
28.33
35.92
Operating Profit
4.99
5.9
7.17
6.17
6.02
6.07
5.68
7.29
2.94
3.61
3.18
5.34
OPM %
18.61%
17.13%
15.01%
11.24%
13.25%
12.81%
14.08%
11.88%
9.69%
9.38%
10.09%
12.94%
Other Income
0.1
0.51
0.23
0.35
0.35
0.56
0.46
1.35
0.64
0.66
0.69
0.7
Interest
3.07
3.48
3.33
1.63
0.99
0.58
0.37
0.39
0.25
0.25
0.23
0.25
Depreciation
1.49
2.07
2.15
2.35
2.29
2.41
2.32
2.08
1.5
1.15
1.21
1.23
PBT
0.53
0.86
1.92
2.54
3.09
3.64
3.45
6.17
1.83
2.87
2.43
4.56
Tax %
66.04%
-81.4%
43.23%
11.02%
25.89%
26.37%
25.51%
33.23%
42.62%
25.09%
-3.7%
—
Net Profit
0.19
1.55
1.09
2.26
2.3
2.68
2.57
4.12
1.05
2.15
2.53
4.05
EPS (₹)
0.23
1.91
0.99
2.05
2.09
2.43
2.33
3.74
0.95
1.95
2.3
3.67
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4.05
4.05
5.51
5.51
5.51
11.02
11.02
11.02
11.02
11.02
11.02
Reserves
-1.41
0.15
8.69
10.95
13.25
10.42
12.92
17.04
18.09
20.24
22.77
Borrowings
25.32
24.99
16.15
12.87
3.87
8.88
3.13
1
1
1.03
1.11
Other Liabilities
7.25
6.49
13.77
7.81
11
10.73
11.61
9.63
8.45
5.29
7.99
Total Liabilities
35.21
35.68
44.12
37.14
33.63
41.05
38.68
38.69
38.56
37.58
42.89
Fixed Assets
13.15
16.88
14.88
12.65
13.18
13.81
13.84
12.68
12.67
15.27
16.72
CWIP
4.3
0
1.18
2.32
1.78
0.97
0.98
1.53
2.62
0.73
0.9
Investments
0
0
0
1.95
3.09
2.03
0
0
0
0
1.7
Other Assets
17.76
18.8
28.06
20.22
15.58
24.24
23.86
24.48
23.27
21.58
23.57
Total Assets
35.21
35.68
44.12
37.14
33.63
41.05
38.68
38.69
38.56
37.58
42.89
Figures in ₹ Crores

Cash Flow

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
4.03
6.02
9.46
10.31
1.71
0.68
2.93
3.66
-0.21
-0.12
Investing
—
-1.4
-1.23
-2.85
-3.08
-0.6
0.06
-1.26
-2.16
-1.32
0.5
Financing
—
-2.92
-3.78
-4.92
-9.9
4.52
-6.06
-2.42
-0.19
-0.12
-0.16
Net Cash Flow
—
-0.29
1
1.68
-2.67
5.63
-5.32
-0.75
1.31
-1.64
0.23
Free Cash Flow
—
2.54
4.68
7.96
8.02
-0.53
-1.68
1.47
1.07
-2.06
-2.95
CFO/EBITDA
—
57
96
158
184
44
29
64
139
10
3
Figures in ₹ Crores

Ratios

Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
82.61
87.12
118
52.66
52.4
60.7
110
72.94
73.48
79.66
121
Inventory Days
155
105
99.61
42.9
80.96
91.96
93.24
42.29
159
80.31
229
Days Payable
131
98.14
150
55.84
126
118
160
73.3
164
57.72
159
Cash Conversion Cycle
107
93.5
67.84
39.72
7.72
34.59
42.9
41.94
68.01
102
191
Working Capital Days
30.08
30.84
30.79
-6.52
10.29
-10.63
49.96
70.44
95.97
104
168
ROCE %
—
15.19%
17.64%
13.67%
14.9%
14.92%
12.89%
23.34%
6.83%
9.58%
7.53%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Arvee Laboratories insights

56 extracted metrics + investor summaries across FY16–FY27.

Shareholding Pattern

Promot.73.50%Others0.26%Public26.24%As ofSep 2026

Documents

Frequently Asked Questions about Arvee Laboratories

What does Arvee Laboratories (India) Ltd do?
Incorporated in 2012, Arvee Laboratories India Ltd manufactures specialized chemicals[1]
Where is Arvee Laboratories (India) Ltd (ARVEE) listed?
Arvee Laboratories (India) Ltd trades as ARVEE on the NSE.
Which sector does Arvee Laboratories (India) Ltd belong to?
Arvee Laboratories (India) Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the market capitalisation of Arvee Laboratories (India) Ltd?
Arvee Laboratories (India) Ltd has a market capitalisation of ₹206.63 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Arvee Laboratories (India) Ltd?
Arvee Laboratories (India) Ltd trades at a PE ratio of 51.09 as of 28 Oct 2026, on earnings per share of ₹3.67, against a book value of ₹30.66 per share.
What is the 52-week high and low of Arvee Laboratories (India) Ltd?
Over the last 52 weeks Arvee Laboratories (India) Ltd has traded between ₹129.11 and ₹290.78 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Arvee Laboratories (India) Ltd?
Arvee Laboratories (India) Ltd reported a return on equity of 7.48%. Its debt-to-equity ratio is 0.03.

Company Information

Incorporated in 2012, Arvee Laboratories India Ltd manufactures specialized chemicals[1]

Website arveelabs.com
CEO Mr. Shalin Sudhakarbhai Patel
Employees 70
Listed 2021-03-22
Face Value ₹ 10
Shares Outstanding 1,10,20,000

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ARVEE.md for Arvee Laboratories (India) Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month